About
AI Medical Service Inc. is a Japanese med-tech company founded in September 2017 and based in Tokyo's Hareza Tower. The company focuses on developing artificial intelligence software to enhance endoscopic diagnostics, particularly for gastrointestinal cancers such as gastric, colorectal, and esophageal cancers. Their mission is to save lives through early detection of cancers that are often overlooked. The company offers endoscopic AI diagnostic support systems that analyze endoscopic images to identify neoplastic lesions. Their flagship product, the gastroAI-model G, is the first AI device specialized in gastric cancer detection and has completed regulatory review in Singapore. AI Medical Service collaborates with medical institutions in Japan and globally to validate and conduct clinical trials for its technologies, aiming to improve diagnostic accuracy and efficiency in GI cancer screening. With a presence in Tokyo, New York, and Singapore, AI Medical Service serves hospitals and clinics specializing in gastroenterology and endoscopy. The company is committed to ethical AI development and precision medicine, fostering innovation and collaboration among specialists in the field.
Technologies
Keywords
Company Information
-
Employees 49
-
Founded 2017
-
Annual Revenue $5500000
-
Total Funding $122010681
Location
Toshima, Tokyo, Japan
